Nexien BioPharma (NXEN) 10-Q 6 Feb 17 2017 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Document and Entity Information:
Entity Registrant Name	Kinder Holding Corp.
Document Type	10-Q
Document Period End Date	Dec. 31, 2016
Trading Symbol	kdrh
Amendment Flag	false
Entity Central Index Key	1,625,288
Current Fiscal Year End Date	--06-30
Entity Common Stock, Shares Outstanding	22,710,192
Entity Public Float		$ 2,271
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2

KINDER HOLDING CORP. - BALANCE

KINDER HOLDING CORP. - BALANCE SHEETS		Dec. 31, 2016USD ($)	Jun. 30, 2016USD ($)
Current assets:
Cash		$ 0	$ 0
Total current assets		0	0
Total Assets		0	0
Current Liabilities:
Accounts payable - related party		55,000	50,000
Accrued interest		$ 9,205	$ 6,392
Advances from related party		17,191	13,511
Total current liabilities		$ 81,396	$ 69,903
Total liabilities		81,396	69,903
Stockholders' deficit
Preferred stock	[1]
Common stock	[2]	2,271	2,271
Additional paid in capital		54	54
Accumulated deficit		(83,721)	(72,228)
Total Stockholders' deficit		(81,396)	(69,903)
Total Liabilities and Stockholders' Deficit		$ 0	$ 0
[1]	$0.0001 par value; 10,000,000 shares authorized; none issued
[2]	$0.0001 par value; 100,000,000 shares authorized; 22,710,192 issued and outstanding at December 31, 2016 and June 30, 2016.

KINDER HOLDING CORP. - STATEMEN

KINDER HOLDING CORP. - STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Statements of Operations
Revenue	$ 0	$ 0	$ 0	$ 0
Costs and expenses:
General and administrative	3,350	3,350	8,680	8,774
Total costs and expenses	3,350	3,350	8,680	8,774
Other income and expenses
Interest expense	1,440	1,127	2,813	2,187
Total other expenses	1,440	1,127	2,813	2,187
Net loss	$ (4,790)	$ (4,477)	$ (11,493)	$ (10,961)
Basic and diluted per share amounts:
Basic and diluted net income (loss)	$ 0	$ 0	$ 0	$ 0
Weighted average shares outstanding
Basic and diluted	22,710,192	22,710,192	22,710,192	22,710,192

KINDER HOLDING CORP. - STATEME4

KINDER HOLDING CORP. - STATEMENTS OF CASH FLOWS	6 Months Ended
	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Cash flows from operating activities:
Net loss	(11,493)	(10,961)
Adjustments to reconcile net loss to cash used in operating activities:
Imputed interest	0	0
Changes in operating assets and liablities:
Increase (decrease) in accrued interest	$ 2,813	$ 2,187
Cash flows used by operating activities	(8,680)	(8,774)
Cash flows from investing activities:
Cash used in investing activities	$ 0	$ 0
Cash flows from financing activities:
Advances from related party	8,680	8,774
Cash provided by financing activities	$ 8,680	$ 8,774
Change in cash	$ 0	$ 0
Cash - beginning of period	0	0
Cash - end of period	0	0

Note 1. Basis of Presentation

Note 1. Basis of Presentation	6 Months Ended
	Dec. 31, 2016
Notes
Note 1. Basis of Presentation	Note 1. Basis of Presentation The Financial Statements presented herein have been prepared by us in accordance with the accounting policies described in our June 30, 2016 audited financial statements and should be read in conjunction with the notes to financial statements which appear as part of those financial statements. The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on going basis, we evaluate our estimates, including those related to intangible assets, income taxes, insurance obligations and contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other resources. Actual results may differ from these estimates under different assumptions or conditions. In the opinion of Management, the information furnished in these interim financial statements reflects all adjustments necessary for a fair statement of the financial position and results of operations and cash flows as of and for the three and six-month periods ended December 31, 2016 and 2015. All such adjustments are of a normal recurring nature. The Financial Statements have been prepared in accordance with the instructions to Form 10-K and therefore do not include some information and notes necessary to conform with annual reporting requirements. Recently Issued Accounting Pronouncements On November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-16 - Derivatives and Hedging (Topic 815) On November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-17 - Business Combinations (Topic 805) On August 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-15, Presentation of Financial Statements - Going Concerns (Subtopic 205-40) In June 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-12, Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments In June 2014, the FASB issued ASU No. 2014-10: Development Stage Entities (Topic 915)

Note 2. Earnings_loss Per Share

Note 2. Earnings/loss Per Share	6 Months Ended
	Dec. 31, 2016
Notes
Note 2. Earnings/loss Per Share	Note 2. Earnings/Loss Per Share Basic earnings per share is computed by dividing income available to common shareholders (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. Diluted earnings per share assumes that any dilutive convertible securities outstanding were converted, with related preferred stock dividend requirements and outstanding common shares adjusted accordingly. It also assumes that outstanding common shares were increased by shares issuable upon exercise of those stock options for which market price exceeds the exercise price, less shares which could have been purchased by us with the related proceeds. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential shares outstanding would be anti-dilutive. There were no common equivalent shares required to be added back to the basic weighted average shares outstanding in order to compute the diluted weighted average shares outstanding.

Note 3. Related Party Transacti

Note 3. Related Party Transactions	6 Months Ended
	Dec. 31, 2016
Notes
Note 3. Related Party Transactions	Note 3. Related Party Transactions Due to Related Parties: Amounts due to related parties consist of corporate securities compliance services, corporate regulatory and administrative expenses paid or advanced for by our CEO. Such items due totaled $72,191 at December 31, 2016 and $63,511 at June 30, 2016. Amounts due to related party are due on demand and bear interest of 8% per annum. During the six month-period ended December 31, 2016 and 2015, the Company incurred $5,000 and $5,000, respectively, in corporate securities compliance services provided by our CEO. Accrued Interest on Related Parties Advances and Payable: During the six-month periods ended December 31, 2016 and 2015, the Company incurred interest expense on advances made to the Company by its CEO of $2,813 and $2,187, respectively. As of December 31, 2016 and June 30, 2016, we had accrued interest of $9,205 and $6,392, respectively.

Note 4. Stockholders' Equity

Note 4. Stockholders' Equity	6 Months Ended
	Dec. 31, 2016
Notes
Note 4. Stockholders' Equity	Note 4. Stockholders' Equity Common Stock The certificate of incorporation authorize the issuance of 100,000,000 shares of common stock, par value $0.0001. All issued shares of common stock are entitled to one vote per share of common stock. As of December 31, 2016, the Company has 22,710,192 shares of common stock issued and outstanding. Preferred Stock The certificate of incorporation authorize the issuance of 10,000,000 shares of preferred stock with a par value of $0.0001 per share. None are issued Stock Based Compensation There were no grants of employee or non-employee stock or options in either period ended December 31, 2016 and 2015.

Note 5. Going Concern

Note 5. Going Concern	6 Months Ended
	Dec. 31, 2016
Notes
Note 5. Going Concern	Note 5. Going Concern The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established any source of revenue to cover its operating costs, and as such, has incurred an operating loss since inception. Further, as of December 31, 2016, the cash resources of the Company were insufficient to meet its current business plan. These and other factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Note 6. Subsequent Events

Note 6. Subsequent Events	6 Months Ended
	Dec. 31, 2016
Notes
Note 6. Subsequent Events	Note 6. Subsequent Events The Company had no subsequent events after December 31, 2016 to the date the financial statements were issued.